Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

248.95
Delayed Data
As of Jul 26
 +1.10 / +0.44%
Today’s Change
195.50
Today|||52-Week Range
340.34
-20.34%
Year-to-Date
3 Stocks Improving Performance Of The Health Care Sector
Jul 26 / TheStreet.com - Paid Partner Content
Teva taps euro bond market ahead of ECB meeting
Jul 20 / FT.com - Paid Partner Content
Jerome Dodson Comments on Allergan
Jul 26 / GuruFocus News - Paid Partner Content
What Awaits Boston Scientific (BSX) in Q2 Earnings?
Jul 19 / Zacks.com - Paid Partner Content
Jerome Dodson's Parnassus Fund 2nd Quarter Commentary
Jul 26 / GuruFocus News - Paid Partner Content
Hologic (HOLX) Q3 Earnings: A Surprise in the Cards?
Jul 19 / Zacks.com - Paid Partner Content
Jim Cramer -- I Agree With the Analysts on Gap, Allergan
Jul 25 / TheStreet.com - Paid Partner Content
Illumina (ILMN) to Report Q2 Earnings: What's in the Cards?
Jul 19 / Zacks.com - Paid Partner Content
5 Incredibly Cheap Big Pharma Stocks
Jul 25 / MotleyFool.com - Paid Partner Content
Edwards Lifesciences (EW) Q2 Earnings: Will It Be a Miss?
Jul 18 / Zacks.com - Paid Partner Content
Analysts' Actions -- Allergan, Alaska Air, Tableau, PulteGroup and More
Jul 25 / TheStreet.com - Paid Partner Content
Teva finalises bond sale of up to $16bn
Jul 18 / FT.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Top 7 Research Reports for July 15, 2016
Jul 15 / Zacks.com - Paid Partner Content
Synergy Pharma Offers Lots of Synergies
Jul 22 / TheStreet.com - Paid Partner Content
Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain
Jul 14 / Zacks.com - Paid Partner Content
Synergy Pharma Offers Suitors Lots of Synergy
Jul 22 / TheStreet.com - Paid Partner Content
Why are Allergan (AGN) and Teva Pharma (TEVA) Stocks Up Today?
Jul 13 / Zacks.com - Paid Partner Content
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Jul 21 / TheStreet.com - Paid Partner Content
Teva Raises Q2 Guidance; to Unveil 2016-2019 View
Jul 13 / Zacks.com - Paid Partner Content
Weitz Funds Comments on Allergan
Jul 20 / GuruFocus News - Paid Partner Content
Shire boosted by FDA approval of dry eye drug
Jul 12 / FT.com - Paid Partner Content
Weitz Funds' 2nd Quarter 2016 Value Fund Commentary
Jul 20 / GuruFocus News - Paid Partner Content
20 stocks to buy after Brexit chaos
Jun 28 / CNNMoney.com
Wally Weitz's Partners Value Fund 2Q 2016 Quarterly Commentary
Jul 20 / GuruFocus News - Paid Partner Content